The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Bioline Rx Ltd ADR’s stock clocked out at $0.68, down -12.48% from its previous closing price of $0.77. In other words, the price has decreased by -$12.48 from its previous closing price. On the day, 0.74 million shares were traded. BLRX stock price reached its highest trading level at $0.7272 during the session, while it also had its lowest trading level at $0.65.
Ratios:
To gain a deeper understanding of BLRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.05 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.55.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Maxim Group on May 18, 2017, Upgraded its rating to Buy and sets its target price to $3 from $1 previously.
On February 13, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $3.
Maxim Group Downgraded its Buy to Hold on August 12, 2016, whereas the target price for the stock was revised from $4 to $1.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLRX now has a Market Capitalization of 54222828 and an Enterprise Value of 825247616. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.66 while its Price-to-Book (P/B) ratio in mrq is 3.76. Its current Enterprise Value per Revenue stands at 70.806 whereas that against EBITDA is -22.007.
Stock Price History:
The Beta on a monthly basis for BLRX is 1.47, which has changed by -0.4306569 over the last 52 weeks, in comparison to a change of 0.24841464 over the same period for the S&P500. Over the past 52 weeks, BLRX has reached a high of $2.53, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is -1.33%, while the 200-Day Moving Average is calculated to be -35.66%.
Shares Statistics:
It appears that BLRX traded 349.14K shares on average per day over the past three months and 272750 shares per day over the past ten days. A total of 79.96M shares are outstanding, with a floating share count of 79.52M. Insiders hold about 0.56% of the company’s shares, while institutions hold 4.31% stake in the company. Shares short for BLRX as of 1722384000 were 276385 with a Short Ratio of 0.79, compared to 1719532800 on 324292. Therefore, it implies a Short% of Shares Outstanding of 276385 and a Short% of Float of 0.34999999.
